# Delfi Diagnostics, Inc. — Form D

Delfi Diagnostics, Inc. of Palo Alto, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-18. The offering totals $60.0M, of which $34.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-12-18
- Form: D
- Accession: 0000905148-25-004422
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $34.3M
- Remaining: $25.7M
- Investors: 50
- Date of first sale: 2025-12-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-567314

## Issuer

- Name: Delfi Diagnostics, Inc.
- CIK: 0001783735
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1810 Embarcadero Road, Palo Alto, CA, 94303
- Phone: 410-961-9015

## Officers, directors & promoters (28)

_Showing 25 of 28 people._

| Name | Role | Location |
| --- | --- | --- |
| Michael B Dybbs | Director | Palo Alto, CA |
| Rishi B Gupta | Director | Palo Alto, CA |
| Elizabeth B Homans | Director | Palo Alto, CA |
| Justin B Kao | Director | Palo Alto, CA |
| Susan Tousi | Director | Palo Alto, CA |
| Jacob B Van Naarden | Director | Palo Alto, CA |
| Victor B Velculescu | Director | Palo Alto, CA |
| Greg B Yap | Director | Palo Alto, CA |
| Peter B Bach | Executive Officer | Palo Alto, CA |
| Amoolya B Singh | Executive Officer | Palo Alto, CA |
| Lee-Ann B Smith-Freeman | Executive Officer | Palo Alto, CA |
| Susan Tousi | Executive Officer | Palo Alto, CA |
| Rishi Gupta | Director | New York, NY |
| Michael Dybbs | Director | Half Moon Bay, CA |
| Greg Yap | Director | CAMBRIDGE, MA |
| William Stevens | Executive Officer | Halethorpe, MD |
| Peter Bach | Executive Officer | Baltimore, MD |
| Elizabeth Homans | Director | Baltimore, MD |
| Justin Kao | Director | Baltimore, MD |
| Jennifer Buechel | Executive Officer | Baltimore, MD |
| Victor Velculescu | Director | Baltimore, MD |
| Victor Velculescu | Executive Officer | Baltimore, MD |
| Victor Velculescu | Promoter | Baltimore, MD |
| Douglas Schenkel | Executive Officer | Baltimore, MD |
| Jacob Van Naarden | Director | Baltimore, MD |

## Other filings by this issuer (4)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-07-25](https://search.stillhousedata.com/formd/0001783735-22-000002) | D | $225.0M | $225.0M |
| [2021-01-27](https://search.stillhousedata.com/formd/0001567619-21-001585) | D | $101.1M | $101.1M |
| [2019-08-27](https://search.stillhousedata.com/formd/0001567619-19-017584) | D | $5.5M | $5.5M |
| [2019-08-13](https://search.stillhousedata.com/formd/0001567619-19-016457) | D | $15K | $15K |

## More

- [CIK 1783735 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1783735&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000905148-25-004422.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.